Julie Clarke

Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases

D. Liénard, Alexander M.M. Eggermont, Heimen Schraffordt Koops et al. · Melanoma Research · 1999 · 148 citations

Medicine, Oncology, Pharmacotherapy +17

Pilot feasibility study examining a structured self‐management diabetes education programme, <scp>DESMOND</scp>‐<scp>ID</scp>, targeting HbA_1c in adults with intellectual disabilities

Laurence Taggart, Maria Truesdale, Marian Carey et al. · Diabetic Medicine · 2017 · 39 citations · Full text

Medicine, Health Education, Special Education +17

Chemotherapy for Poor Risk Germ Cell Tumours An Independent Evaluation of the POM B/ACE Regime

M.H. Cullen, Peter Harper, C.M. Woodroffe et al. · British Journal of Urology · 1988 · 26 citations

Medicine, Oncology, Chemotherapy +14

A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix

RE Coleman, Julie Clarke, M L Slevin et al. · Cancer Chemotherapy and Pharmacology · 1990 · 18 citations

Medicine, Oncology, Cervical Disease +15

MALIGNANT MELANOMATA: SOME POINTS IN TREATMENT AND PROGNOSIS

Julie Clarke · Australian and New Zealand Journal of Surgery · 1952 · 14 citations

Medicine, Oncology, Surgery +12